Autosomal dominant tubulointerstitial kidney disease-REN
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Autosomal dominant tubulointerstitial kidney disease-REN (ADTKD-REN) is part of a group of inherited disorders (collectively called autosomal dominant tubulointerstitial kidney disease or ADTKD) that cause a gradual loss of kidney function. In people with ADTKD-REN, the signs and symptoms of kidney disease usually become apparent during childhood or adolescence.
Video picks for Genetic conditionsVideo library
Overview
Description
Autosomal dominant tubulointerstitial kidney disease-REN (ADTKD-REN) is part of a group of inherited disorders (collectively called autosomal dominant tubulointerstitial kidney disease or ADTKD) that cause a gradual loss of kidney function. In people with ADTKD-REN, the signs and symptoms of kidney disease usually become apparent during childhood or adolescence.
The signs and symptoms of ADTKD-REN can include:
Low blood pressure (hypotension)
Mildly increased levels of potassium in the blood (hyperkalemia)
A low number of healthy red blood cells (anaemia) during childhood
High blood levels of a chemical called uric acid that is usually removed from the body in urine (hyperuricemia)
A form of arthritis caused by a buildup of uric acid crystals in the joints (gout)
Low blood levels and decreased activity of a protein called renin, which is produced in the kidneys
Kidney damage due to illness, dehydration, or certain medications
Treatment may help stabilize kidney function in some people with ADTKD-REN, which can improve or prevent some of the signs and symptoms. However, as the disease progresses, the kidneys lose the ability to properly filter fluid and waste products from the body. This causes chronic kidney disease, which can lead to kidney failure. People with kidney failure require either dialysis to remove waste from the blood or a kidney transplant.
Frequency
Although ADTKD is the third most common genetic kidney disease, ADTKD-REN is rare. At least 50 families with this condition have been reported in the scientific literature.
Causes
Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in one copy of the REN gene in each cell cause ADTKD-REN. The REN gene provides instructions for making renin, which plays an important role in regulating blood pressure and fluid levels in the body.
The pathogenic variants in the REN gene that cause ADTKD-REN lead to the production of an abnormal version of renin that does not function properly. In affected individuals, functional renin is only produced from the copy of the gene without a pathogenic variant. As a result, people with ADTKD-REN produce less functional renin. In addition, the abnormal renin accumulates inside kidney cells, causing these cells to gradually die off. This leads to the progressive loss of kidney function seen in people with ADTKD-REN.
Learn more about the gene associated with Autosomal dominant tubulointerstitial kidney disease-REN
Inheritance
As the name suggests, this condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Other Names for This Condition
ADTKD-REN
ADTKD4
Familial juvenile hyperuricemic nephropathy type 2
FJHN type 2
REN-associated familial juvenile hyperuricemic nephropathy
REN-associated FJHN
REN-associated kidney disease
REN-related kidney disease
Additional Information & Resources
Genetic Testing Information
Genetic and Rare Diseases Information Center
Patient Support and Advocacy Resources
Catalog of Genes and Diseases from OMIM
Scientific Articles on PubMed
Patient picks for Genetic conditions

Kidney and urinary tract
Polycystic kidney disease
Polycystic kidney disease (PKD) causes many fluid-filled sacs (cysts) to develop in the kidneys.
by Dr Colin Tidy, MRCGP

Cancer
Kidney cancer
Most cases of kidney cancer develop in people between the ages of 60 and 70 although it can affect any age group. The most common early symptom is blood in the urine. If kidney cancer is diagnosed at an early stage, there is a good chance of a cure. A description of what kidneys are and how they work is at the bottom of this article.
by Dr Philippa Vincent, MRCGP

Tests and investigations
Routine kidney function blood test
There are various different ways of measuring how well the kidneys are working. The most common way is by measuring a substance called creatinine with a blood test, and calculating something called the estimated glomerular filtration rate (eGFR). Usually, other substances such as urea and salts in the blood (potassium and sodium) are measured as well.
by Dr Doug McKechnie, MRCGP

Kidney and urinary tract
Glomerulonephritis
Glomerulonephritis is the name given to a range of conditions that can affect the kidney, specifically the glomeruli of the kidney. The glomeruli become damaged, commonly because of a problem with the body's immune system. Many people with glomerulonephritis may not notice any symptoms initially. However, salt and excess fluid can build up in the body if the glomeruli and kidneys are not working normally. This can lead to complications such as high blood pressure and, in some cases, chronic kidney disease, which may lead to end-stage kidney disease. Treatment will depend on the underlying cause as well as the severity of symptoms.
by Dr Toni Hazell, FRCGP

Heart health and blood vessels
Cardiovascular disease
Cardiovascular diseases (CVD) is a general term to describe diseases of the heart or blood vessels. The cause of most cardiovascular disease is a build-up of atheroma - a fatty deposit within the inside lining of arteries. The blood flow to the heart muscle may also be restricted by a blood clot in an artery taking blood to the heart muscle (coronary artery disease). Atheroma or a blood clot may also restrict or prevent blood going to the brain (cerebrovascular disease) or to the legs and feet (peripheral arterial disease). There are lifestyle factors that can be taken to reduce the risk of forming atheroma. These include not smoking; choosing healthy foods; a low salt intake; regular physical activity; keeping your weight and waist size down; drinking alcohol in moderation. Your blood pressure and cholesterol level are also important. All people aged over 40 years should have a cardiovascular health risk assessment - usually available at your GP surgery. If you have a high risk of developing a cardiovascular disease, treatment to reduce high blood pressure (hypertension) and/or cholesterol may be advised.
by Dr Colin Tidy, MRCGP

Surgery and procedures
Kidney biopsy
A kidney biopsy involves taking a small sample of tissue from the kidney. Cells from the kidney can then be looked at in detail. It is used to diagnose and monitor certain conditions. Note: the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. Always follow the instructions given by your doctor or local hospital.
by Dr Doug McKechnie, MRCGP
Related patient information and medicines

Patient information leaflet
Polycystic kidney disease
Polycystic kidney disease (PKD) causes many fluid-filled sacs (cysts) to develop in the kidneys. The most common type of PKD is an inherited condition called autosomal dominant polycystic kidney disease (ADPKD). The two common problems that develop are high blood pressure High blood pressure and chronic kidney disease (CKD) Chronic kidney disease..

Patient information leaflet
Kidney cancer
Most cases of kidney cancer develop in people between the ages of 60 and 70 although it can affect any age group. A description of what kidneys are and how they work is at the ... What is kidney cancer. There are several types of kidney cancer but over 9 out of 10 kidney cancers are "renal cell cancer". This is sometimes called renal.

Patient information leaflet
Routine kidney function blood test
There are various different ways of measuring how well the kidneys are working. The most common way is by measuring a substance called creatinine with a blood test, and calculating so... Some laboratories also measure chloride and bicarbonate routinely, whereas in other labs these are only done if the clinician specifically asks for them. These.

Patient information leaflet
Glomerulonephritis
Glomerulonephritis is the name given to a range of conditions that can affect the kidney, specifically the glomeruli of the kidney. However, salt and excess fluid... Each kidney is about the size of a large orange but bean-shaped. The word 'renal' is a descriptive medical word, meaning related to the kidney. For example, a renal physician is a.

Patient information leaflet
Cardiovascular disease
Cardiovascular diseases (CVD) is a general term to describe diseases of the heart or blood vessels. The cause of most cardiovascular disease is a build-up of atheroma - a fatty deposit within the inside lining of arteries. Diabetes Diabetes. Chronic kidney disease Chronic kidney disease causing diminished kidney function. Fixed risk factors - ones.

Patient information leaflet
Kidney biopsy
A kidney biopsy involves taking a small sample of tissue from the kidney. Cells from the kidney can then be looked at in detail. It is used to diagnose and monitor certain conditions. Note : the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. The sample is looked.
Further reading and references
- Autosomal dominant tubulointerstitial kidney disease-REN; MedlinePlus, National Library of Medicine.
- Beck BB, Trachtman H, Gitman M, Miller I, Sayer JA, Pannes A, Baasner A, Hildebrandt F, Wolf MT. Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD. Am J Kidney Dis. 2011 Nov;58(5):821-5. doi: 10.1053/j.ajkd.2011.06.029. Epub 2011 Sep 8.
- Bleyer AJ, Kidd KO, Zivna M, Kmoch S. Autosomal Dominant Tubulointerstitial Kidney Disease: A Review. Am J Kidney Dis. 2025 Nov;86(5):677-689. doi: 10.1053/j.ajkd.2025.05.015. Epub 2025 Aug 18.
- Bleyer AJ, Wolf MT, Kidd KO, Zivna M, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: more than just HNF1beta. Pediatr Nephrol. 2022 May;37(5):933-946. doi: 10.1007/s00467-021-05118-4. Epub 2021 May 22.
- Bleyer AJ, Zivna M, Hulkova H, Hodanova K, Vyletal P, Sikora J, Zivny J, Sovova J, Hart TC, Adams JN, Elleder M, Kapp K, Haws R, Cornell LD, Kmoch S, Hart PS. Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone. Clin Nephrol. 2010 Dec;74(6):411-22. doi: 10.5414/cnp74411.
- Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O; Kidney Disease: Improving Global Outcomes. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. Kidney Int. 2015 Oct;88(4):676-83. doi: 10.1038/ki.2015.28. Epub 2015 Mar 4.
- Econimo L, Schaeffer C, Zeni L, Cortinovis R, Alberici F, Rampoldi L, Scolari F, Izzi C. Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD. Kidney Int Rep. 2022 Aug 29;7(11):2332-2344. doi: 10.1016/j.ekir.2022.08.012. eCollection 2022 Nov.
- Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, Inker LA, Levin A, Mehrotra R, Palevsky PM, Perazella MA, Tong A, Allison SJ, Bockenhauer D, Briggs JP, Bromberg JS, Davenport A, Feldman HI, Fouque D, Gansevoort RT, Gill JS, Greene EL, Hemmelgarn BR, Kretzler M, Lambie M, Lane PH, Laycock J, Leventhal SE, Mittelman M, Morrissey P, Ostermann M, Rees L, Ronco P, Schaefer F, St Clair Russell J, Vinck C, Walsh SB, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020 Jun;97(6):1117-1129. doi: 10.1016/j.kint.2020.02.010. Epub 2020 Mar 9.
- Shamam YM, Hashmi MF. Autosomal Dominant Tubulointerstitial Kidney Disease. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK568710/
- Zivna M, Hulkova H, Matignon M, Hodanova K, Vylet'al P, Kalbacova M, Baresova V, Sikora J, Blazkova H, Zivny J, Ivanek R, Stranecky V, Sovova J, Claes K, Lerut E, Fryns JP, Hart PS, Hart TC, Adams JN, Pawtowski A, Clemessy M, Gasc JM, Gubler MC, Antignac C, Elleder M, Kapp K, Grimbert P, Bleyer AJ, Kmoch S. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet. 2009 Aug;85(2):204-13. doi: 10.1016/j.ajhg.2009.07.010. Epub 2009 Aug 6.
- Zivna M, Kidd K, Kmoch S, Bleyer AJ. Autosomal Dominant Tubulointerstitial Kidney Disease - REN. 2011 Apr 5 [updated 2020 Dec 10]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK53700/
- Zivna M, Kidd K, Zaidan M, Vyletal P, Baresova V, Hodanova K, Sovova J, Hartmannova H, Votruba M, Treslova H, Jedlickova I, Sikora J, Hulkova H, Robins V, Hnizda A, Zivny J, Papagregoriou G, Mesnard L, Beck BB, Wenzel A, Tory K, Haeffner K, Wolf MTF, Bleyer ME, Sayer JA, Ong ACM, Balogh L, Jakubowska A, Laszkiewicz A, Clissold R, Shaw-Smith C, Munshi R, Haws RM, Izzi C, Capelli I, Santostefano M, Graziano C, Scolari F, Sussman A, Trachtman H, Decramer S, Matignon M, Grimbert P, Shoemaker LR, Stavrou C, Abdelwahed M, Belghith N, Sinclair M, Claes K, Kopel T, Moe S, Deltas C, Knebelmann B, Rampoldi L, Kmoch S, Bleyer AJ. An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes. Kidney Int. 2020 Dec;98(6):1589-1604. doi: 10.1016/j.kint.2020.06.041. Epub 2020 Aug 1.
- Zivna M, Kidd KO, Baresova V, Hulkova H, Kmoch S, Bleyer AJ Sr. Autosomal dominant tubulointerstitial kidney disease: A review. Am J Med Genet C Semin Med Genet. 2022 Sep;190(3):309-324. doi: 10.1002/ajmg.c.32008. Epub 2022 Oct 17.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

